Carcinoma, Small Cell
Oncology
1
Pipeline Programs
2
Companies
2
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
1
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
AstraZenecaCAMBRIDGE, United Kingdom
1 programIMFINZI Study in Patients With Extensive Stage Small Cell Lung CancerN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Boehringer IngelheimBI 2536
AstraZenecaIMFINZI Study in Patients With Extensive Stage Small Cell Lung Cancer
Clinical Trials (2)
Total enrollment: 271 patients across 2 trials
BI 2536 Second Line Monotherapy in SCLC
Start: Feb 2007Est. completion: Jun 200823 patients
Phase 2Completed
IMFINZI Study in Patients With Extensive Stage Small Cell Lung Cancer
Start: Apr 2021Est. completion: Jul 2023248 patients
N/ACompleted
Related Jobs in Oncology
Senior Research Associate, Immuno-Oncology
SystImmune
2m ago
$60K - $85K/yr
Research Associate I/II, Immuno-Oncology
SystImmune
2m ago
Office Administrator
SystImmune
2m ago
$60K - $80K/yr
Scientist/Sr Scientist
TwoStep Therapeutics
San Carlos
13m ago
Working Student Office Management Support (m/f/d)
Mindpeak
Hamburg
16m ago
Senior Medical Project Manager (m/f/d)
Mindpeak
Hamburg
16m ago
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
2 companies competing in this space